|
(11) | EP 2 101 725 A1 |
| (12) |
|
|
|
|
|||||||||||||||||||||||
| (54) | USE OF L-CARNITINE OR OF ALKANOYL L-CARNITINES FOR THE PREPARATION OF A PHYSIOLOGICAL SUPPLEMENT OR MEDICAMENT FOR OPHTHALMIC USE IN THE FORM OF EYE DROPS |